Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19Helena Janols, Noemí Corbacho, Silvia Herrera et al.|JAMA|2021Cited by 723
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE studyOliver A. Cornely, Sílvia Gómez-Zorrilla, José Miguel Cisneros et al.|Journal of Antimicrobial Chemotherapy|2019Cited by 123
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Nicole G. Weiskopf, Talita Duarte‐Salles et al.|Clinical Epidemiology|2022Cited by 26